COMMUNIQUÉS West-GlobeNewswire

Reata Pharmaceuticals, Inc. Announces Second Quarter 2019 Financial Results and an Update on Development Programs
08/08/2019
Conference Call With Management Scheduled for Today, August 8, 2019 IRVING, Texas, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a clinical-stage biopharmaceutical company, today [...]
Protalix BioTherapeutics Reports Second Quarter 2019 Results and Provides Corporate Update
08/08/2019
CARMIEL, Israel, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE:PLX), a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic [...]
Mersana Therapeutics Announces Second Quarter 2019 Financial Results and Provides Business Updates
08/08/2019
Patient Dosing in XMT-1536 Phase 1 Expansion Study Expected to Commence in Third Quarter 2019 Ended Second Quarter 2019 with $128 Million in Cash CAMBRIDGE, Mass., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Mersana Therapeutics [...]
Genesis Healthcare Reports Solid Second Quarter 2019 Results
08/08/2019
KENNETT SQUARE, Pa., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Genesis Healthcare, Inc. (Genesis, or the Company) (NYSE:GEN), one of the largest post-acute care providers in the United States, today announced operating results [...]
RadNet Reports Second Quarter Financial Results and Increases Financial Guidance Levels
08/08/2019
Revenue increased 18.3% to $289.1 million in the second quarter of 2019 from $244.4 million in the second quarter of 2018 Adjusted EBITDA (1) increased 13.0% to $43.1 million in the second quarter of 2019 from $38.2 [...]
Evoke Pharma to Resubmit Gimoti™ NDA Based on FDA Meeting Minutes and Announces Second Quarter 2019 Financial Results
08/08/2019
NDA resubmission anticipated in fourth quarter 2019 SOLANA BEACH, Calif., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for [...]
Novo Nordisk A/S - Share repurchase programme
08/08/2019
Bagsværd, Denmark, 8 August 2019 – On 7 May 2019, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) [...]
Capital Senior Living Corporation Reports 2019 Second Quarter Results
08/08/2019
DALLAS, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Capital Senior Living Corporation (the “Company”) (NYSE: CSU), one of the nation’s largest operators of senior housing communities, announced today operating and financial [...]
Tecan schedules conference call on August 15th to discuss half year 2019 financial results
08/08/2019
Männedorf, Switzerland, August 8, 2019 – The Tecan Group AG (SIX Swiss Exchange: TECN) will hold a conference call to discuss the financial results for the first half year 2019 on Thursday, August 15th, 2019 at 10:00 [...]
AgraFlora Organics Enters Into Non-Binding CBD Commercialization and Distribution LOI; Commences Discussions With One of Canada’s Largest Food Retailers To Achieve National Branded and Private Label CBD Product Exposure
08/08/2019
VANCOUVER, British Columbia, Aug. 08, 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“ AgraFlora ” or the “ Company ”) ( CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF ), a growth oriented and diversified [...]
Active Biotech AB: Interim report January – June 2019
08/08/2019
Significant events during the second quarter In accordance with the Board’s proposal, the Extraordinary General Meeting on April 4, 2019, resolved to approve the sale of the company’s property to Estea AB Active Biotech [...]
Curetis Group Company Ares Genetics Launches Service Laboratory for NGS-based Molecular Drug Resistance Testing
08/08/2019
Initial focus on non-diagnostic testing with Next Generation Sequencing (NGS) for infection control, outbreak management and research First commercial orders received and processed Vienna, Austria, and Holzgerlingen, [...]
Change to the Executive Leadership Team
08/08/2019
Please read the full announcement in PDF Attachment 2019_28_Change_to_the_Executive_Leadership_Team_EN
Interim report for the first half of 2019
08/08/2019
Read the full announcement in PDF Attachment 2019_27_Q22019_CompanyAnnouncement_FINAL_EN
Mesa Laboratories, Inc. Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes
08/08/2019
Source: Mesa Laboratories, Inc. – August 7, 2019 11:20 PM ET Lakewood, Colo., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (“Mesa”) today announced the pricing of concurrent underwritten [...]
Telix Pharmaceuticals and GenesisCare Commence ENHANCING Prostate Cancer Clinical Study
08/08/2019
MELBOURNE, Australia and SYDNEY, Australia, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted [...]
Helix Biopharma Corp. Receives U.S. FDA Approval for Phase Ib/II Pancreatic Trial
08/08/2019
RICHMOND HILL, Ontario, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment [...]
MyDx Announces Letter to Shareholders
08/08/2019
SAN DIEGO, Aug. 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- MyDx, Inc. ( OTC: MYDX ), a leader in science based cannabis health technologies, today issued a press release with the following letter to shareholders. [...]
New England Journal of Medicine Publishes Results from Pivotal Study of WAYLIVRA® (volanesorsen) in Patients with Familial Chylomicronemia Syndrome
07/08/2019
Mean triglyceride levels decreased 77% in volanesorsen-treated patients versus an 18% increase in patients in placebo group Akcea launching WAYLIVRA in the European Union BOSTON and CARLSBAD, Calif, Aug. 07, 2019 (GLOBE [...]

Pages